Matches in Wikidata for { <http://www.wikidata.org/entity/Q64836578> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q64836578 description "clinical trial" @default.
- Q64836578 description "ensayu clínicu" @default.
- Q64836578 description "klinisch onderzoek" @default.
- Q64836578 description "клінічне випробування" @default.
- Q64836578 name "Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)" @default.
- Q64836578 name "Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)" @default.
- Q64836578 type Item @default.
- Q64836578 label "Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)" @default.
- Q64836578 label "Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)" @default.
- Q64836578 prefLabel "Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)" @default.
- Q64836578 prefLabel "Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)" @default.
- Q64836578 P1050 Q64836578-B88F4E2F-8C4A-4755-89F4-4D56F49ECBD3 @default.
- Q64836578 P1132 Q64836578-18C63ECF-D142-4B21-A507-64018B3E2EEC @default.
- Q64836578 P1476 Q64836578-09F29165-2D3B-45A6-A552-FB1C84792C92 @default.
- Q64836578 P17 Q64836578-5E9790D7-CEB2-4920-8204-5B8E83FDA5E1 @default.
- Q64836578 P17 Q64836578-AAC006A4-04C7-49E9-8827-3AF55FC1E2D1 @default.
- Q64836578 P17 Q64836578-B0E4FF07-5F2D-4853-9354-60156D6BE8F8 @default.
- Q64836578 P2899 Q64836578-053503B4-E024-47E4-8EED-14556EC7638D @default.
- Q64836578 P3098 Q64836578-8CE3C2B9-DE9F-4A87-823E-470E123E3AF4 @default.
- Q64836578 P31 Q64836578-FE8758A0-34C3-4683-B352-2D3A746B1D51 @default.
- Q64836578 P4135 Q64836578-ED079EF9-8BD5-452A-B59E-FBE04B4E7DDE @default.
- Q64836578 P580 Q64836578-D188045B-E1DE-43EA-A009-80122C783C09 @default.
- Q64836578 P582 Q64836578-F4E69798-7540-478F-A909-C7BED1DE7C21 @default.
- Q64836578 P6099 Q64836578-F472002F-4280-4C34-9697-431FFD6BCBD0 @default.
- Q64836578 P8363 Q64836578-76FE19A6-E757-4FEE-B444-C224FAE5137C @default.
- Q64836578 P1050 Q1546498 @default.
- Q64836578 P1132 "+84" @default.
- Q64836578 P1476 "An Adaptive Design Study for the Assessment of the Safety, Tolerability, and Pharmacokinetics of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)" @default.
- Q64836578 P17 Q16 @default.
- Q64836578 P17 Q30 @default.
- Q64836578 P17 Q408 @default.
- Q64836578 P2899 "+18" @default.
- Q64836578 P3098 "NCT03261739" @default.
- Q64836578 P31 Q30612 @default.
- Q64836578 P4135 "+65" @default.
- Q64836578 P580 "2017-08-28T00:00:00Z" @default.
- Q64836578 P582 "2018-08-24T00:00:00Z" @default.
- Q64836578 P6099 Q5452194 @default.
- Q64836578 P8363 Q78089383 @default.